School of Life Science and Biotechnology, Dalian University of Technology, Dalian, People's Republic of China.
School of Life Sciences, Tsinghua University, Beijing, People's Republic of China.
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00534-18. Print 2018 Sep 1.
is one of the most common nosocomial opportunistic pathogens and usually exhibits multiple-drug resistance. Phage therapy, a potential therapeutic to replace or supplement antibiotics, has attracted much attention. However, very few phages have been well characterized because of the lack of efficient genome-editing tools. Here, Cas9 from and a single guide RNA (sgRNA) were used to modify a virulent bacteriophage, phiKpS2. We first evaluated the distribution of sgRNA activity in phages and proved that it is largely inconsistent with the predicted activity from current models trained on eukaryotic cell data sets. A simple CRISPR-based phage genome-editing procedure was developed based on the discovery that homologous arms as short as 30 to 60 bp were sufficient to introduce point mutation, gene deletion, and swap. We also demonstrated that weak sgRNAs could be used for precise phage genome editing but failed to select random recombinants, possibly because inefficient cleavage can be tolerated through continuous repair by homologous recombination with the uncut genomes. Small frameshift deletion was proved to be an efficient way to evaluate the essentiality of phage genes. By using the abovementioned strategies, a putative promoter and nine genes of phiKpS2 were successfully deleted. Interestingly, the holin gene can be deleted with little effect on phiKpS2 infection, but the reason is not yet clear. This study established an efficient, time-saving, and cost-effective procedure for phage genome editing, which is expected to significantly promote the development of bacteriophage therapy. In the present study, we have addressed efficient, time-saving, and cost-effective CRISPR-based phage genome editing of phage, which has the potential to significantly expand our knowledge of phage-host interactions and to promote applications of phage therapy. The distribution of sgRNA activity was first evaluated in phages. Short homologous arms were proven to be enough to introduce point mutation, small frameshift deletion, gene deletion, and swap into phages, and weak sgRNAs were proven useful for precise phage genome editing but failed to select random recombinants, all of which makes the CRISPR-based phage genome-editing method easier to use.
是最常见的医院获得性机会致病菌之一,通常表现出多种药物耐药性。噬菌体治疗作为一种替代或补充抗生素的潜在治疗方法,引起了广泛关注。然而,由于缺乏有效的基因组编辑工具,很少有噬菌体得到很好的表征。在这里,我们使用 Cas9 来自 和一个单链向导 RNA (sgRNA) 来修饰一种毒性噬菌体 phiKpS2。我们首先评估了 sgRNA 活性在噬菌体中的分布,并证明它与当前基于真核细胞数据集训练的模型预测的活性在很大程度上不一致。基于同源臂短至 30 到 60 个碱基对就足以引入点突变、基因缺失和交换的发现,我们开发了一种简单的基于 CRISPR 的噬菌体基因组编辑程序。我们还证明,弱 sgRNA 可用于精确的噬菌体基因组编辑,但未能选择随机重组体,可能是因为通过与未切割基因组的同源重组进行连续修复,可以容忍低效切割。小移码缺失被证明是评估噬菌体基因必要性的有效方法。通过使用上述策略,成功删除了 phiKpS2 的一个假定启动子和九个基因。有趣的是,holin 基因的缺失对 phiKpS2 的感染几乎没有影响,但原因尚不清楚。本研究建立了一种高效、省时、经济有效的噬菌体基因组编辑程序,有望显著促进噬菌体治疗的发展。在本研究中,我们解决了噬菌体的高效、省时、经济有效的基于 CRISPR 的噬菌体基因组编辑问题,这有可能极大地扩展我们对噬菌体-宿主相互作用的认识,并促进噬菌体治疗的应用。首先评估了 sgRNA 活性在噬菌体中的分布。证明短同源臂足以引入点突变、小移码缺失、基因缺失和交换到噬菌体中,弱 sgRNA 可用于精确的噬菌体基因组编辑,但未能选择随机重组体,这使得基于 CRISPR 的噬菌体基因组编辑方法更容易使用。